Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial.

OBJECTIVE: Evaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19. METHODS: During the first pandemic wave, 140 consenting and eligible hospitalized adult participants with mild-moderate symptomatic disease (specific standard RT-PCR assay positive) were selected as per a convenience sample, and randomized (1:1 ratio) to an open-label (assessor blind) two-arm multicentric drug trial; standard of care (SOC as per Indian guidelines) versus AYUSH 64 combined with SOC (AYUSH plus). Participants were assessed daily and discharged once clinical recovery (CR, primary efficacy) was achieved which was based on a predetermined set of criteria (resolution of symptoms, normal peripheral oximetry, and negative specific RT-PCR assay). Each participant was followed using an indigenous software program(mobile phone) and completed a 12-week study period. The dose of AYUSH 64 was 2 tablets oral, 500 mg each, bid for 12 weeks (AYUSH plus only). Significant P was <0.05 (two-sided). On randomization, the groups were found well matched. RESULTS: The mean interval time from randomization to CR was significantly superior in the AYUSH plus group [mean 6.45 days versus 8.26 days, 95% Confidence Interval of the difference -3.02 to -0.59 (P = 0.003, Student's 't test] as per-protocol analysis (134 participants); significant (P = 0.002) on an intention to treat analysis. 70% of the participants in AYUSH plus recovered during the first week (P = 0.046, Chi-square) and showed a significantly better change in physical health, fatigue, and quality of life measures. 48 adverse events, mostly mild and gut related, were reported by each group. There were 20 patient withdrawals (8 in AYUSH plus) but none due to an AE. There were no deaths. Daily assessment (hospitalization) and supervised drug intake ensured robust efficacy data. The open-label design was a concern (study outcome). CONCLUSIONS: AYUSH 64 in combination with SOC hastened recovery, reduced hospitalization, and improved health in COVID-19. It was considered safe and well-tolerated. Further clinical validation (Phase III) is required. TRIAL REGISTRATION: CTRI/2020/06/025557.

1D alignment of Co(II) metalated porphyrin-napthalimide based self-assembled nanowires for photocatalytic hydrogen evolution.

The splitting of water into hydrogen and oxygen under visible light is an emerging phenomenon in green energy technology. Nevertheless, selecting an appropriate photocatalyst is rather significant to enhance hydrogen production on a large scale. In this context, organic photocatalysts have received considerable attention owing to their larger surface area, control in diffusion adsorption, nanostructures and electronic properties. Herein, we have developed five either free base or transition metalated porphyrin-napthalimide based donor-acceptor systems (PN1-PN5) and studied their morphology, electronic properties and catalytic behaviour. Detailed studies suggest that the Co(II) substituent D-A system (PN2) displayed a well-aligned one-dimensional (1D) nanowire with high electrical conductivity promoting remarkable photocatalytic hydrogen production rate (18 mM g-1 h-1) when compared to that of porphyrin-based derivatives reported until now. Thus, these results propose to investigate diverse metalated π-conjugated materials as photocatalysts for hydrogen production.

Phenothiazine functional materials for organic optoelectronic applications.

Phenothiazine (PTZ) is one of the most extensively investigated S, N heterocyclic aromatic hydrocarbons due to its unique optical, electronic properties, flexibility of functionalization, low cost, and commercial availability. Hence, PTZ and its derivative materials have been attractive in various optoelectronic applications in the last few years. In this prospective, we have focused on the most significant characteristics of PTZ and highlighted how the structural modifications such as different electron donors or acceptors, length of the π-conjugated system or spacers, polar or non-polar chains, and other functional groups influence the optoelectronic properties. This prospective provides a recent account of the advances in phenothiazine derivative materials as an active layer(s) for optoelectronic (viz. dye sensitized solar cells (DSSCs), perovskite solar cells (PSCs), organic solar cells (OSCs), organic light-emitting diodes (OLEDs), organic field-effect transistor (OFETs), chemosensing, nonlinear optical materials (NLOs), and supramolecular self-assembly applications. Finally, future prospects are discussed based on the structure-property relationship in PTZ-derivative materials. This overview will pave the way for researchers to design and develop new PTZ-functionalized structures and use them for various organic optoelectronic applications.

Metallated Macrocyclic Derivatives as a Hole - Transporting Materials for Perovskite Solar Cells.

Spiro-OMeTAD is widely used as thehole-transporting material (HTM) in perovskite solar cells (PSC), which extracts positive charges and protects the perovskite materials from metal electrode, setting a new world-record efficiency of more than 20 %. Spiro-OMeTAD layer engross moisture leading to the degradation of perovskite, and therefore, has poor air stability. It is also expensive therefore limiting scale-up, so macrocyclic metal complex derivatives (MMDs) could be a suitable replacement. Our review covers low-cost, high yield hydrophobic materials with minimal steps required for synthesis of efficient HTMs for planar/mesostructured PSCs. The MMDs based devices demonstrated PCEs around 19 % and showed stability for a longer duration, indicating that MMDs are a promising alternative to spiro-OMeTAD and also easy to scale-up via solution approach. Additionally, this review describes how optical and electrical properties of MMDs change with chemical structure, allowing for the design of novel hole-mobility materials to achieve negligible hysteresis and act as effective functional barriers against moisture which results in a significant increase in the stability of the device. We provide an overview of the apt green-synthesis, characterization, stability and implementation of the various classes of macrocyclic metal complex derivatives as HTM for photovoltaic applications.

Photoinduced energy transfer in carbazole-BODIPY dyads.

A series of carbazole (CBZ)-boron dipyrromethene (BODIPY) based donor-acceptor dyads, CB1, CB2, and CB3, with CBZ as an energy donor, tethered together with spacers of varied sizes i.e., phenyl bridge, biphenyl bridge and diphenylethyne bridge, respectively, are reported. The newly synthesized dyads were characterized by various spectroscopic techniques. A comparison of the absorption and electrochemical data of the dyads with their reference compounds (i.e., 9-phenyl-9H-carbazole (C0) and N,N'-difluoroboryl-1,3,7,9-tetramethyl-5-phenyldipyrrin (B0)) revealed minimal ground-state interactions between the chromophores. Selective excitation of CBZ in the dyads at 290 nm resulted in the quenching of the CBZ emission followed by the appearance of BODIPY emission, revealing efficient energy transfer from singlet excited CBZ (1CBZ*) to BODIPY. The photoinduced energy transfer phenomenon was studied in three different solvents of varying polarity. The driving forces for energy transfer (ΔGEN) for all the dyads were found to be exothermic. The rate constants for energy transfer, kENT, measured by the femtosecond transient absorption technique in toluene were found to be in the range of 0.8-2.0 × 1010 s-1, depending on the type of spacer between the CBZ and BODIPY entities, and were in close agreement with the theoretically estimated rates according to the Förster energy transfer model. In contrast, selective excitation of BODIPY in these dyads at 485 nm resulted in small quenching of the BODIPY emission, suggesting a lack of major photochemical events originating from 1BODIPY*.